Harrison G - Search Results

1

A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.

Flaig TW, Glodé M, Gustafson D, van Bokhoven A, Tao Y, Wilson S, Su LJ, Li Y, Harrison G, Agarwal R, Crawford ED, Lucia MS, Pollak M. Flaig TW, et al. Among authors: harrison g. Prostate. 2010 Jun 1;70(8):848-55. doi: 10.1002/pros.21118. Prostate. 2010. PMID: 20127732 Clinical Trial.

2

Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells.

Flaig TW, Su LJ, Harrison G, Agarwal R, Glodé LM. Flaig TW, et al. Among authors: harrison g. Int J Cancer. 2007 May 1;120(9):2028-33. doi: 10.1002/ijc.22465. Int J Cancer. 2007. PMID: 17230508

3

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients.

Flaig TW, Gustafson DL, Su LJ, Zirrolli JA, Crighton F, Harrison GS, Pierson AS, Agarwal R, Glodé LM. Flaig TW, et al. Invest New Drugs. 2007 Apr;25(2):139-46. doi: 10.1007/s10637-006-9019-2. Epub 2006 Nov 1. Invest New Drugs. 2007. PMID: 17077998 Clinical Trial.

4

Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.

Flaig TW, Nordeen SK, Lucia MS, Harrison GS, Glodé LM. Flaig TW, et al. J Urol. 2007 Apr;177(4):1229-37. doi: 10.1016/j.juro.2006.11.032. J Urol. 2007. PMID: 17382696 Review.

5

Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line.

Qi L, Singh RP, Lu Y, Agarwal R, Harrison GS, Franzusoff A, Glode LM. Qi L, et al. Cancer Biol Ther. 2003 Sep-Oct;2(5):526-31. doi: 10.4161/cbt.2.5.452. Cancer Biol Ther. 2003. PMID: 14614320 Free article.

6

Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.

Tyagi A, Agarwal C, Harrison G, Glode LM, Agarwal R. Tyagi A, et al. Among authors: harrison g. Carcinogenesis. 2004 Sep;25(9):1711-20. doi: 10.1093/carcin/bgh180. Epub 2004 Apr 29. Carcinogenesis. 2004. PMID: 15117815

7

Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.

Tyagi A, Raina K, Singh RP, Gu M, Agarwal C, Harrison G, Glode LM, Agarwal R. Tyagi A, et al. Among authors: harrison g. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3248-55. doi: 10.1158/1535-7163.MCT-07-2006. Mol Cancer Ther. 2007. PMID: 18089718

8

Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the gonadotropin-releasing hormone receptor.

Qi L, Nett TM, Allen MC, Sha X, Harrison GS, Frederick BA, Crawford ED, Glode LM. Qi L, et al. Cancer Res. 2004 Mar 15;64(6):2090-5. doi: 10.1158/0008-5472.can-3192-2. Cancer Res. 2004. PMID: 15026348

9

Current challenges of gene therapy for prostate cancer.

Harrison GS, Glode LM. Harrison GS, et al. Oncology (Williston Park). 1997 Jun;11(6):845-50, 856; discussion 856-8, 861. Oncology (Williston Park). 1997. PMID: 9189941 Free article. Review.

10

GnRH-PAP hormonotoxin targets cytotoxicity to prostate cancer cell lines.

Qi L, Nett TM, Allen MC, Sha X, Harrison GS, Frederick BA, Glode LM. Qi L, et al. Urol Res. 2003 Dec;31(6):374-7. doi: 10.1007/s00240-003-0352-z. Epub 2003 Sep 13. Urol Res. 2003. PMID: 13680022

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,448 results

Search Page

Filters